TOP TIERMARKET NEWSWIRE
News & sentiment

UNICYCIVE THERAPEUTI (UNCY) — News & AI sentiment

UNICYCIVE THERAPEUTI (UNCY) news roundup. 40 stories aggregated over the last 30 days. Average 30-day sentiment is 40.2/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
40
avg sentiment 40.2/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

UNCY news in the last 24 hours, 7 days, 30 days and 90 days

How much UNCY coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowUNCY storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days4040.2/100UNCY headlines →
Last 90 days14041.9/100UNCY headlines →

Latest stories on UNCY

Nov 4
Nov 4
Nov 2
Oct 31
Oct 29
Oct 29
Oct 28
Oct 27
Oct 26
Oct 26
Oct 26
Oct 26
Oct 24
Oct 23
Oct 23
Oct 22
Oct 22
Oct 22
Oct 21
Why is Unicycive Therapeutics stock rallying today?
Investing.com Markets63 · neutralgeneral
Oct 21
Oct 21
Oct 21
Unicycive stock jumps as FDA accepts OLC drug resubmission
Investing.com Markets64 · neutralproduct/pr
Oct 21
Oct 21
Oct 21
Open UNCY in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →